The latest news, announcements and press releases from Soter Bio.
The Woodlands, Texas— February 24, 2026/ Cision / – Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a strategic collaboration with Soter Bio, a CDMO specializing in RNA and RNA–lipid nanoparticle (LNP) manufacturing for research and GMP applications. Together, the companies will support integrated manufacturing pathways for complex cell therapy programs requiring coordinated biomolecule and cellular processing.
This is the News section of the company profile page for Soter Bio on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
